DFT383 in Pediatric Participants With Nephropathic Cystinosis | MicrobiomeTrials← Back to trialsNCT06910813
DFT383 in Pediatric Participants With Nephropathic Cystinosis
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-06-02Est. Completion: 2031-05-28
Enrollment target: 30 participants Locations- University of California at San Diego - Rady Children's Hospital, San Diego, California, United States
- Stanford University - Stanford Children's Health, Stanford, California, United States
- Emory University School of Medicine - Children's Healthcare of Atlanta (recuiting Cohort 0), Atlanta, Georgia, United States
- Baylor College of Medicine - Texas Children's Hospital (recuiting Cohort 0), Houston, Texas, United States
Other microbiome trials you might be interested in
Glycogen Storage Disease Type IAGlycogen Storage Disease Type IGlycogen Storage Disease Type IBGlycogen Storage Disease Xi
The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to dete…
Hartford, United StatesEst. completion Mar 2027
Fanconi Anemia Complementation Group AFanconi Anemia
This is a long-term safety and efficacy follow-up study for subjects with Fanconi Anaemia Subtype A who have been treate…
Madrid, SpainEst. completion Jan 17, 2034
Novartis Pharmaceuticals